J SM. PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS. scholar [Internet]. 2019 Sep. 29 [cited 2024 Nov. 6];8(2.2). Available from: https://jconsortium.com/index.php/scholar/article/view/93